PUBLIC COMPANY

$ARTVArtiva Biotherapeutics, Inc.

San Diego, CA, USupdated 1mo ago

SEC EDGAR Yahoo Finance

community read0 votes

pipeline

2

marketed

0

phase 3

0

catalysts ytd

0

approvals ytd

0

recalls ytd

0

Pipeline(2)

pipeline depth2 products

1Preclinical1Phase 2

Phase 2

GCC-4001

Idiopathic Inflammatory Myopathy (IIM)

Preclinical

GCC-2004

B-Cell Non-Hodgkin Lymphoma

Upcoming

no upcoming catalysts on record

Recent(90d)

nothing in the last 90 days

view all catalysts →

🐶 Hiring Signal

No open roles indexed yet — view Artiva Biotherapeutics, Inc. jobs →

News

no news has mentioned this company yet

$ARTV

Active trials

Insider activity

source: SEC Form 4

routine RSU / option mechanics (6)

Mar 10, 26grantHuston Thad Allen · Chief Financial Officer220,000 sh
Feb 18, 26grantSorg Elaine K. · director27,500 sh
Feb 15, 26tax coverAslan Fred · President and CEO14,600 sh
Feb 15, 26tax coverBush Jennifer · COO, CLO, Secy, Compliance Off3,515 sh
Feb 15, 26tax coverHoran Christopher · Chief Tech Operations Officer2,187 sh
Feb 15, 26tax coverRaymon Heather · SVP, Research and Development1,521 sh

comments(0)

5-min edit window · permanent after that

sign in to leave a comment · permanent archive after 5 minutes

no comments yet — first sniff?

Data sources

SEC EDGAR

last refreshed 13m ago

Found something off?